222 related articles for article (PubMed ID: 17561839)
1. Neuromuscular paralysis and recovery in mice injected with botulinum neurotoxins A and C.
Morbiato L; Carli L; Johnson EA; Montecucco C; Molgó J; Rossetto O
Eur J Neurosci; 2007 May; 25(9):2697-704. PubMed ID: 17561839
[TBL] [Abstract][Full Text] [Related]
2. Antagonism of botulinum toxin A-mediated muscle paralysis by 3, 4-diaminopyridine delivered via osmotic minipumps.
Adler M; Capacio B; Deshpande SS
Toxicon; 2000 Oct; 38(10):1381-8. PubMed ID: 10758273
[TBL] [Abstract][Full Text] [Related]
3. Effect of 3,4-diaminopyridine on rat extensor digitorum longus muscle paralyzed by local injection of botulinum neurotoxin.
Adler M; Macdonald DA; Sellin LC; Parker GW
Toxicon; 1996 Feb; 34(2):237-49. PubMed ID: 8711757
[TBL] [Abstract][Full Text] [Related]
4. Persistence of botulinum neurotoxin A demonstrated by sequential administration of serotypes A and E in rat EDL muscle.
Adler M; Keller JE; Sheridan RE; Deshpande SS
Toxicon; 2001; 39(2-3):233-43. PubMed ID: 10978741
[TBL] [Abstract][Full Text] [Related]
5. Dynamics of motor nerve terminal remodeling unveiled using SNARE-cleaving botulinum toxins: the extent and duration are dictated by the sites of SNAP-25 truncation.
Meunier FA; Lisk G; Sesardic D; Dolly JO
Mol Cell Neurosci; 2003 Apr; 22(4):454-66. PubMed ID: 12727443
[TBL] [Abstract][Full Text] [Related]
6. Effects of hydroxamate metalloendoprotease inhibitors on botulinum neurotoxin A poisoned mouse neuromuscular junctions.
Thyagarajan B; Potian JG; Garcia CC; Hognason K; Capková K; Moe ST; Jacobson AR; Janda KD; McArdle JJ
Neuropharmacology; 2010 Jun; 58(8):1189-98. PubMed ID: 20211192
[TBL] [Abstract][Full Text] [Related]
7. Botulinum neurotoxin serotypes A and C do not affect motor units survival in humans: an electrophysiological study by motor units counting.
Eleopra R; Tugnoli V; Quatrale R; Gastaldo E; Rossetto O; De Grandis D; Montecucco C
Clin Neurophysiol; 2002 Aug; 113(8):1258-64. PubMed ID: 12140005
[TBL] [Abstract][Full Text] [Related]
8. Sprouting of mammalian motor nerve terminals induced by in vivo injection of botulinum type-D toxin and the functional recovery of paralysed neuromuscular junctions.
Comella JX; Molgo J; Faille L
Neurosci Lett; 1993 Apr; 153(1):61-4. PubMed ID: 8390032
[TBL] [Abstract][Full Text] [Related]
9. Ouabain exacerbates botulinum neurotoxin-induced muscle paralysis via progression of muscle atrophy in mice.
Fujikawa R; Muroi Y; Unno T; Ishii T
J Toxicol Sci; 2010 Dec; 35(6):795-805. PubMed ID: 21139329
[TBL] [Abstract][Full Text] [Related]
10. 3,4-diaminopyridine reverses paralysis in botulinum neurotoxin-intoxicated diaphragms through two functionally distinct mechanisms.
Bradford AB; Machamer JB; Russo TM; McNutt PM
Toxicol Appl Pharmacol; 2018 Feb; 341():77-86. PubMed ID: 29366638
[TBL] [Abstract][Full Text] [Related]
11. Use-dependent potentiation of voltage-gated calcium channels rescues neurotransmission in nerve terminals intoxicated by botulinum neurotoxin serotype A.
Beske PH; Hoffman KM; Machamer JB; Eisen MR; McNutt PM
Sci Rep; 2017 Nov; 7(1):15862. PubMed ID: 29158500
[TBL] [Abstract][Full Text] [Related]
12. Recovery of mouse neuromuscular junctions from single and repeated injections of botulinum neurotoxin A.
Rogozhin AA; Pang KK; Bukharaeva E; Young C; Slater CR
J Physiol; 2008 Jul; 586(13):3163-82. PubMed ID: 18467364
[TBL] [Abstract][Full Text] [Related]
13. Botulinum neurotoxins A and E undergo retrograde axonal transport in primary motor neurons.
Restani L; Giribaldi F; Manich M; Bercsenyi K; Menendez G; Rossetto O; Caleo M; Schiavo G
PLoS Pathog; 2012 Dec; 8(12):e1003087. PubMed ID: 23300443
[TBL] [Abstract][Full Text] [Related]
14. The rat Digit Abduction Score (DAS) assay: a physiological model for assessing botulinum neurotoxin-induced skeletal muscle paralysis.
Broide RS; Rubino J; Nicholson GS; Ardila MC; Brown MS; Aoki KR; Francis J
Toxicon; 2013 Sep; 71():18-24. PubMed ID: 23707612
[TBL] [Abstract][Full Text] [Related]
15. Effects of enzymatically inactive recombinant botulinum neurotoxin type A at the mouse neuromuscular junctions.
Baskaran P; Lehmann TE; Topchiy E; Thirunavukkarasu N; Cai S; Singh BR; Deshpande S; Thyagarajan B
Toxicon; 2013 Sep; 72():71-80. PubMed ID: 23810945
[TBL] [Abstract][Full Text] [Related]
16. Botulinum neurotoxins: from paralysis to recovery of functional neuromuscular transmission.
Meunier FA; Schiavo G; Molgó J
J Physiol Paris; 2002; 96(1-2):105-13. PubMed ID: 11755789
[TBL] [Abstract][Full Text] [Related]
17. Capsaicin protects mouse neuromuscular junctions from the neuroparalytic effects of botulinum neurotoxin a.
Thyagarajan B; Krivitskaya N; Potian JG; Hognason K; Garcia CC; McArdle JJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):361-71. PubMed ID: 19654265
[TBL] [Abstract][Full Text] [Related]
18. Comparison of the action of types A and F botulinum toxin at the rat neuromuscular junction.
Kauffman JA; Way JF; Siegel LS; Sellin LC
Toxicol Appl Pharmacol; 1985 Jun; 79(2):211-7. PubMed ID: 2988154
[TBL] [Abstract][Full Text] [Related]
19. Different effects of types A and B botulinum toxin on transmitter release at the rat neuromuscular junction.
Sellin LC; Thesleff S; Dasgupta BR
Acta Physiol Scand; 1983; 119(2):127-33. PubMed ID: 6140815
[TBL] [Abstract][Full Text] [Related]
20. Acute and chronic effects of botulinum neurotoxin a on the mammalian neuromuscular junction.
Baskaran P; Thyagarajan B
Muscle Nerve; 2014 Aug; 50(2):206-15. PubMed ID: 24218344
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
